home / stock / cmopf / cmopf quote
Last: | $80.25 |
---|---|
Change Percent: | 0.0% |
Open: | $80.25 |
Close: | $80.25 |
High: | $80.25 |
Low: | $80.25 |
Volume: | 13 |
Last Trade Date Time: | 06/21/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$80.25 | $80.25 | $80.25 | $80.25 | $80.25 | 13 | 06-21-2024 |
$80 | $80 | $80 | $80 | $80 | 65 | 06-03-2024 |
$80 | $80 | $80 | $80 | $80 | 2 | 04-26-2024 |
$76.6 | $76.6 | $76.6 | $76.6 | $76.6 | 14 | 04-25-2024 |
$76 | $76 | $76 | $76 | $76 | 100 | 04-11-2024 |
$76.7 | $76.7 | $76.7 | $76.7 | $76.7 | 31 | 03-29-2024 |
$76.7 | $76.7 | $76.7 | $76.7 | $76.7 | 31 | 03-28-2024 |
$73.7 | $73.7 | $73.7 | $73.7 | $73.7 | 2 | 03-26-2024 |
$75.55 | $75.55 | $75.55 | $75.55 | $75.55 | 12 | 03-25-2024 |
$73.22 | $73.22 | $73.22 | $73.22 | $73.22 | 1,365 | 03-22-2024 |
$75.9 | $73.55 | $75.9 | $75.9 | $73.55 | 200 | 03-20-2024 |
$75.1 | $75.1 | $75.1 | $75.1 | $75.1 | 100 | 03-18-2024 |
$80 | $79.86 | $80 | $80 | $79.86 | 31 | 03-08-2024 |
$75.185 | $75.185 | $75.185 | $75.185 | $75.185 | 50 | 03-01-2024 |
$68.9 | $68.9 | $68.9 | $68.9 | $68.9 | 1,000 | 01-08-2024 |
$64.9 | $64.9 | $64.9 | $64.9 | $64.9 | 1,000 | 01-03-2024 |
$52.65 | $52.65 | $52.65 | $52.65 | $52.65 | 70 | 12-11-2023 |
$48.75 | $48.75 | $48.75 | $48.75 | $48.75 | 50 | 12-05-2023 |
$48.7 | $48.7 | $48.7 | $48.7 | $48.7 | 100 | 11-30-2023 |
$41.5 | $41.5 | $41.5 | $41.5 | $41.5 | 1 | 10-17-2023 |
News, Short Squeeze, Breakout and More Instantly...
Chi Mei Optoelectronics Corp Sponsored Reg S GDR Company Name:
CMOPF Stock Symbol:
OTCMKTS Market:
Dublin, Ireland--(Newsfile Corp. - June 18, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) reported that its partner and exclusive licensee of Lumeblue ® (Methylene Blue MMX ® ) for China, China Medical System Holdings Limited (“CMS”) (S...
Dublin, Ireland--(Newsfile Corp. - June 3, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) with its Cosmo Intelligent Medical Devices division (“Cosmo IMD”) is consolidating its strategy to accelerate the adoption of responsible and regulated AI in ...
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - May 31, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced its final audited results for the financial year 2023. Financial highlights As previously announced...